Regulations

Lower valuations, corporate carve-outs and resilience to AI disruption are opening up medtech to buyout firms after years of limited access.

Spiraling pharmacy costs are creating a value creation opportunity for PE firms that are able to curb spending, says RX Benefits business development executive Will Statham.

The PE industry’s plucky roots fed its growth into an established industry with a famed reputation. But which part of that story is the one individual investors want to buy into?

With globalisation in retreat, the implications for private investment are complex. In areas like manufacturing, the push is toward reshoring of portfolio company operations. In risk management, many investors see diversifying their global exposure as key.

Will the Trump administration’s America First Investment Policy fundamentally change global capital flows?

Tokenization of real assets is opening up alternatives to a vast new investor universe and jurisdictions are having to respond, say Elliot Refson and Philip Pirecki of Jersey Finance.

With AI becoming a key focus of the Trump administration, its impact on private equity investors in the space remains uncertain.

Outgoing Biden administration says private equity titan 'systemically flouted' laws; KKR accuses DOJ of 'overreach.'

Senator Casey’s concerns stem from Anchor Hocking’s acquisition of the Charleroi Pyrex glassware plant from Corelle Brands after the cookware company exited its bankruptcy proceedings.